Healthcare technology company Roman Health Ventures Inc. is contemplating going public, the operator of telehealth and online pharmacy business Ro is seeking to go public through merger with a Special Purpose Acquisition Company (SPAC).
Ro began as an online pharmacy specializing on selling erectile dysfunction drugs to men. Currently, the company is now a fully certified telehealth company which treats a wide range of diseases, disorders, allergies among other illnesses among men and women.
Citing insider sources, this merger with a blank check company is set to leave the company with a market valuation of over $4 billion.
The sources further said talks are still in their initial stages hence anything can happen and the company decides not to go public opting to seek other capital raising methods like holding financing rounds.
The blank check company in talks with Roman Healht was not revealed by the sources since the company is yet to reveal the matter in the public domain.
Ro is based in New York, it held its last financing round in July which was led by venture fund General Catalyst. The company raised $200 million in the financing round attaining a market valuation of $1.5 billion.
